Marta
Llanos Muñoz

Part Time Assistant Professor (Health Science)

Foto de Marta

Foto de Instituto de Salud Carlos III

Instituto de Salud Carlos III

Madrid, España

Publications in collaboration with researchers from Instituto de Salud Carlos III (3)

2018

First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii183

2017

Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group
Cancer, Vol. 123, Núm. 19, pp. 3709-3716

2012

First-Line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: The phase III MACRO TTD study
Onkologie, Vol. 6, Núm. 2, pp. 96-103